JPS6334122B2 - - Google Patents

Info

Publication number
JPS6334122B2
JPS6334122B2 JP3767981A JP3767981A JPS6334122B2 JP S6334122 B2 JPS6334122 B2 JP S6334122B2 JP 3767981 A JP3767981 A JP 3767981A JP 3767981 A JP3767981 A JP 3767981A JP S6334122 B2 JPS6334122 B2 JP S6334122B2
Authority
JP
Japan
Prior art keywords
enteric
capsules
coated
beeswax
pin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP3767981A
Other languages
Japanese (ja)
Other versions
JPS57154119A (en
Inventor
Tooru Chiba
Yasuaki Muto
Kazumasa Maruyama
Katsuyoshi Minemura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shin Etsu Chemical Co Ltd
Original Assignee
Shin Etsu Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shin Etsu Chemical Co Ltd filed Critical Shin Etsu Chemical Co Ltd
Priority to JP3767981A priority Critical patent/JPS57154119A/en
Publication of JPS57154119A publication Critical patent/JPS57154119A/en
Publication of JPS6334122B2 publication Critical patent/JPS6334122B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は腸溶性カプセルの改良された製造方法
に関するものである。 腸溶性カプセルは医薬品を封入し、服用するか
あるいは坐剤として直腸に投与されるが、従来、
このようなカプセルとしてはゼラチン製のカプセ
ルを基剤としてホルマリンで処理するか、腸溶性
高分子物質で被覆する方法あるいは腸溶性高分子
物質自体でカプセルを製造する方法が知られてい
る。 しかしながら、ゼラチンを基剤とした腸溶性カ
プセルは、ホルマリン処理する場合には胃液に溶
解せず、腸液に溶解するための処理コントロール
が難しく、また腸溶性高分子物質で被覆する場合
にはゼラチンの表面と被覆膜との接着不良が生じ
易い等の問題点がある。 腸溶性高分子物質自体でカプセルを製造するに
は、腸溶性高分子物質の有機溶媒溶液にゼラチン
カプセル製造と同様に成型ピンを浸漬してから、
これを引上げて乾燥し抜き取りを行うが、従来こ
のような製造方法では成型されたカプセルがピン
に固着し、通常の方法では抜き取りが困難であ
る。 本発明者らは前記欠点を解消し、容易に抜き取
りが行える方法を種々検討した結果、浸漬前の成
型ピンに離型剤としてカルナウパロウあるいはミ
ツロウを塗布することにより、カプセルのピンか
らの抜き取りが容易に行えることを見出し、本発
明を完成するにいたつた。 すなわち、本発明は腸溶性高分子物質の溶媒溶
液に成型ピンを浸漬して腸溶性カプセルを製造す
るにあたり、浸漬に先だつて該成型ピン表面にカ
ルナウパロウまたはミツロウを塗布することを特
徴とする腸溶性カプセルの製造方法に関するもの
である。 これを説明すると、カルナウパロウおよびミツ
ロウが有機溶媒に接触してもすぐれた離型性を示
し、しかもこれらはカプセルに付着して医薬品と
ともに服用されても、これらが従来から滑沢剤あ
るいは持続性錠剤の崩壊延長剤として使用されて
いることから明らかなとおり、人体に対して無害
であるという利点を有する。 本発明の方法は成型ピンにあらかじめカルナウ
パロウまたはミツロウを塗布するのであるが、こ
の塗布の方法としては溶融したそれらカルナウパ
ロウもしくはミツロウ中に成型ピンを浸漬して引
上げる方法、加熱した成型ピンをそれらカルナウ
パロウもしくはミツロウ中に埋没させる方法、あ
るいはそれら塗布剤のクロロホルムなどの有機溶
媒溶液を成型ピンに塗布する方法などがあるが、
特にこれらに限られるものではなく、他の塗布手
段によつてもよい。 本発明の方法で使用される腸溶性高分子物質と
しては、セルロースアセテートフタレート、ヒド
ロキシプロピルメチルセルロースフタレート、セ
ルロースアセテートサクシネート、ヒドロキシプ
ロピルメチルセルロースアセテートサクシネー
ト、カルボキシメチルエチルセルロースなどのセ
ルロース誘導体、メタクリル酸とメタクリル酸メ
チルエステル共重合体、スチレンとマレイン酸と
の共重合体などのビニル重合体、ポリビニルフタ
レートなどポリビニルアルコール誘導体が例示さ
れる。 また、浸漬液調整のために使用される溶媒は、
腸溶性高分子物質の種類により異なる場合もある
が、一般には有機溶媒または有機溶媒−水混合溶
媒が使用され、この有機溶媒としてはメチルアル
コール、エチルアルコール、イソプロピルアルコ
ールなどのアルコール類、アセトン、メチルエチ
ルケトンのようなケトン類、ジオキサン、メチル
セロソルブ、エチルセロソルブなどのエーテル
類、塩化メチレン等の塩素化炭化水素類などが例
示される。なお、これらは一種類に限られず2種
類以上の混合溶媒あるいは水との混合溶媒として
使用してもよい。腸溶性高分子物質の濃度はピン
による成型操作の容易性等を考慮して決定される
が、通常5〜40重量%の範囲が用いられる。肉薄
のカプセルを得ることが目的の場合には低濃度の
浸漬液を、また肉厚のカプセルを得ることが目的
の場合には高濃度の粘稠な浸漬液をそれぞれ使用
することが望ましい。 なお、浸漬液には必要に応じて着色剤、きよう
味きよう臭剤、香料、可塑剤、充填剤など各種添
加剤を配合することは差支えないが、それらは腸
溶性高分子物質がもつ本来の機能に悪影響を及ぼ
さない範囲にとどめるべきである。 腸溶性カプセルは具体的につぎの工程により製
造される。 まず、成型ピンにカルナウパロウまたはミツロ
ウを塗布し、これを腸溶性高分子物質の溶媒溶液
中に浸漬し、ついでこのピンを引き上げピンの周
りに形成された粘稠な膜を乾燥し、こうして形成
されたカプセルをピンから抜き取り、不必要部分
を切断除去することにより所望寸法、形状を有す
る腸溶性カプセルが得られる。カプセルに残留す
る溶媒(有機溶媒)を少なくする目的のためにさ
らに後乾燥を行う場合もある。 つぎに具体的実施例をあげる。 実施例 各種離型剤を塗布したゼラチンカプセル1号の
ボデイに相当する形状のSUS−304製の成型ピン
を腸溶性高分子物質の有機溶媒あるいは有機溶媒
−水混合溶媒の溶液中に浸漬し、引き上げた後風
乾1時間、50℃1時間さらに70℃1時間乾燥した
ものについて手で抜き取り試験を行い、離型性を
比較した。結果は次表に示した通りであり、カル
ナウパロウとミツロウが良好な離型性能を示し
た。 なお、ここに使用した腸溶性高分子物質は下記
のとおりである。 ヒドロキシプロピルメチルセルロースアセテート
サクシネート(HPMC−ASと略す) 無水グルコース単位1個当りの置換数 ヒドロキシプロポキシル基 0.26 メトキシル基 1.82 アセチル基 0.43 サクシノイル基 0.43 ヒドロキシプロピルメチルセルロースフタレート
(信越化学製 HP−55) 無水グルコース単位1個当りの置換数 ヒドロキシプロポキシル基 0.25 メトキシル基 1.85 フタリル基 0.72 カルボキシメチルエチルセルロース(CMECと
略す) 無水グルコース単位1個当りの置換数 カルボキシメチル基 0.55 エトキシル基 2.14 メタクリル酸−メタクリル酸メチルエステル共重
合体(PMA−MMAと略す) メタクリル酸;メタクリル酸メチル= 55:45(モル比) また次表において溶媒の項で使用した略記号は
下記のとおりである。 DCM:ジクロロメタン、EtOH:エチルアル
コール、MeOH:メチルアルコール、IPA:
イソプロピルアルコール。
The present invention relates to an improved method for manufacturing enteric-coated capsules. Enteric-coated capsules enclose pharmaceutical products and are either ingested or administered rectally as suppositories.
As such capsules, methods are known in which capsules made of gelatin are treated with formalin as a base, coated with an enteric polymer material, or capsules are manufactured from the enteric polymer material itself. However, gelatin-based enteric-coated capsules do not dissolve in gastric fluid when treated with formalin, making it difficult to control the process to dissolve them in intestinal fluid, and when coated with enteric-coated polymeric substances, gelatin There are problems such as poor adhesion between the surface and the coating film. To manufacture capsules using the enteric polymer material itself, immerse a molding pin in an organic solvent solution of the enteric polymer material in the same manner as in the production of gelatin capsules, and then
The capsule is pulled up, dried, and extracted, but in conventional manufacturing methods, the molded capsule adheres to the pin, making it difficult to extract using normal methods. The inventors of the present invention investigated various methods for solving the above-mentioned drawbacks and making it easier to remove the capsules, and found that by applying carnaupal wax or beeswax as a release agent to the molding pin before immersion, the capsule can be easily removed from the pin. The present invention was completed based on the discovery that this can be done. That is, the present invention provides an enteric-coated capsule characterized by applying carnaupal wax or beeswax to the surface of the molding pin prior to dipping the molding pin in a solvent solution of an enteric-coated polymer substance to produce an enteric-coated capsule. The present invention relates to a method for manufacturing capsules. To explain this, carnaupal wax and beeswax exhibit excellent mold release properties even when they come into contact with organic solvents, and even when they are attached to capsules and taken together with pharmaceuticals, they have traditionally been used as lubricants or long-lasting tablets. As is clear from the fact that it is used as a disintegration prolonging agent, it has the advantage of being harmless to the human body. In the method of the present invention, a molded pin is coated with carnaupal wax or beeswax in advance. Methods for this application include immersing the molding pin in molten carnaupal wax or beeswax and pulling it up; Alternatively, there is a method of immersing it in beeswax, or a method of applying a solution of the coating agent in an organic solvent such as chloroform to the molding pin.
The application method is not particularly limited to these, and other application methods may be used. Enteric polymeric substances used in the method of the present invention include cellulose derivatives such as cellulose acetate phthalate, hydroxypropyl methyl cellulose phthalate, cellulose acetate succinate, hydroxypropyl methyl cellulose acetate succinate, carboxymethyl ethyl cellulose, methacrylic acid and methacrylic acid. Examples include vinyl polymers such as methyl ester copolymers and copolymers of styrene and maleic acid, and polyvinyl alcohol derivatives such as polyvinyl phthalate. In addition, the solvent used for preparing the immersion liquid is
Although it may differ depending on the type of enteric polymer substance, generally an organic solvent or a mixed solvent of organic solvent and water is used, and organic solvents include alcohols such as methyl alcohol, ethyl alcohol, and isopropyl alcohol, acetone, and methyl ethyl ketone. Examples include ketones such as dioxane, ethers such as methyl cellosolve and ethyl cellosolve, and chlorinated hydrocarbons such as methylene chloride. Note that these solvents are not limited to one type, and may be used as a mixed solvent of two or more types or as a mixed solvent with water. The concentration of the enteric polymer substance is determined taking into account the ease of molding operation using pins, etc., and is usually in the range of 5 to 40% by weight. When the purpose is to obtain thin-walled capsules, it is desirable to use a low-concentration immersion liquid, and when the purpose is to obtain thick-walled capsules, it is desirable to use a high-concentration and viscous immersion liquid. It should be noted that various additives such as coloring agents, flavoring agents, fragrances, plasticizers, fillers, etc. may be added to the dipping liquid as necessary, but these additives may It should be kept within a range that does not adversely affect the original function. Enteric-coated capsules are specifically manufactured by the following steps. First, carnaupal wax or beeswax is applied to a molding pin, which is dipped into a solvent solution of an enteric polymeric substance.Then, the pin is pulled up and the viscous film that has formed around the pin is dried. By pulling out the capsule from the pin and cutting off unnecessary parts, an enteric-coated capsule having the desired size and shape can be obtained. In some cases, post-drying may be performed to reduce the amount of solvent (organic solvent) remaining in the capsule. Next, a specific example will be given. Example A molding pin made of SUS-304 and having a shape corresponding to the body of gelatin capsule No. 1 coated with various mold release agents is immersed in a solution of an enteric polymer substance in an organic solvent or an organic solvent-water mixed solvent. After being pulled up, the pieces were air-dried for 1 hour, then 50°C for 1 hour, and then 70°C for 1 hour, and a manual sampling test was conducted to compare the mold releasability. The results are shown in the table below, and carnaupal wax and beeswax showed good mold release performance. The enteric polymer substances used here are as follows. Hydroxypropyl methylcellulose acetate succinate (abbreviated as HPMC-AS) Number of substitutions per anhydroglucose unit Hydroxypropoxyl group 0.26 Methoxyl group 1.82 Acetyl group 0.43 Succinoyl group 0.43 Hydroxypropyl methylcellulose phthalate (Shin-Etsu Chemical HP-55) Anhydrous glucose Number of substitutions per unit Hydroxypropoxyl group 0.25 Methoxyl group 1.85 Phthalyl group 0.72 Carboxymethylethyl cellulose (abbreviated as CMEC) Number of substitutions per anhydroglucose unit Carboxymethyl group 0.55 Ethoxyl group 2.14 Methacrylic acid - methacrylic acid methyl ester co Polymer (abbreviated as PMA-MMA) Methacrylic acid; Methyl methacrylate = 55:45 (mole ratio) In addition, the abbreviations used in the solvent section in the following table are as follows. DCM: dichloromethane, EtOH: ethyl alcohol, MeOH: methyl alcohol, IPA:
Isopropyl alcohol.

【表】 ○:離型性良好、△:離型しにくい、×:離型不能
[Table] ○: Good releasability, △: Difficult to release, ×: Unable to release.

Claims (1)

【特許請求の範囲】[Claims] 1 腸溶性高分子物質の溶媒溶液に成型ピンを浸
漬して腸溶性カプセルを製造するにあたり、浸漬
に先だつて該成型ピンにカルナウパロウまたはミ
ツロウを塗布することを特徴とする腸溶性カプセ
ルの製造方法。
1. A method for manufacturing enteric-coated capsules, which comprises applying carnaupal wax or beeswax to the molding pin prior to dipping the molding pin in a solvent solution of an enteric polymeric substance.
JP3767981A 1981-03-16 1981-03-16 Preparation of enteric capsule Granted JPS57154119A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3767981A JPS57154119A (en) 1981-03-16 1981-03-16 Preparation of enteric capsule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3767981A JPS57154119A (en) 1981-03-16 1981-03-16 Preparation of enteric capsule

Publications (2)

Publication Number Publication Date
JPS57154119A JPS57154119A (en) 1982-09-22
JPS6334122B2 true JPS6334122B2 (en) 1988-07-08

Family

ID=12504294

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3767981A Granted JPS57154119A (en) 1981-03-16 1981-03-16 Preparation of enteric capsule

Country Status (1)

Country Link
JP (1) JPS57154119A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01124605A (en) * 1987-11-04 1989-05-17 Aderans Co Ltd Wig having shape holding member
JPH052567Y2 (en) * 1988-04-21 1993-01-22

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01124605A (en) * 1987-11-04 1989-05-17 Aderans Co Ltd Wig having shape holding member
JPH052567Y2 (en) * 1988-04-21 1993-01-22

Also Published As

Publication number Publication date
JPS57154119A (en) 1982-09-22

Similar Documents

Publication Publication Date Title
EP0018605B1 (en) Enterosoluble capsule and method for its preparation
US4138013A (en) Enteric capsules
US4816259A (en) Process for coating gelatin capsules
KR101762460B1 (en) Acid resistant capsules
US4310928A (en) Surgeon's glove and talc free process for forming same
US5330759A (en) Enteric coated soft capsules and method of preparation thereof
JPS5867616A (en) Enteric microcapsule and its preparation
JPH064531B2 (en) Colon disintegrating hard capsule
JP2552937B2 (en) Pharmaceutical hard capsule and method for producing the same
KR900005795B1 (en) Process for coating solid pharma-ceutical preparations
RU2019104876A (en) ACID RESISTANT CAPSULES
EP0781541A3 (en) Method and apparatus for manufacturing pharmaceutical cellulose capsules - sizing the capsule
JPS6043330B2 (en) Self-supporting packaging or capsules for enclosing drugs
JPS62266060A (en) Production of medical hard capsule
JPS6334122B2 (en)
JPH0347246B2 (en)
US6752953B2 (en) Method for manufacturing hard non-gelatin pharmaceutical capsules
US2897122A (en) Enteric coated product
CA1062613A (en) Enteric capsules
CN113677331A (en) Capsule shell comprising core-shell polymer and cellulose
JPH0371415B2 (en)
JPS607492B2 (en) enteric-coated capsules
JPS587607B2 (en) Method for manufacturing enteric-coated preparations
CN1116043C (en) Process for preparation of coated azithromycin micropill
DE10107878A1 (en) Portions of laundry, dish-washing or other detergent in dimensionally-stable hollow molding(s) with at least one compartment, used especially in commercial machine machines and for cleaning